Las dos instituciones han firmado un convenio centrado en tres proyectos científicos sobre estrategias combinadas de inmunoterapia, moléculas para estimular el sistema inmune y terapias CAR-T
Read moreA study led by IBEC and ISGlobal has demonstrated the antileishmanial potential of an antimalarial compound. Initially designed for malaria, this drug shows high efficacy against leishmaniasis, repres...
Read moreEndowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...
Read moreIn an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...
Read moreIn the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...
Read moreThe Nucleic Acids Chemistry group, led by Prof. Ramon Eritja’s of the IQAC (CSIC), is participating in a multidisciplinary network for Myotonic Dystrophy Type 1 (DM1) with other 6 research groups...
Read moreDescriben las principales diferencias morfológicas existentes en las estructuras internas de los colmillos de hombres y mujeres de poblaciones actuales y destaca la utilidad de esta pieza dental para...
Read moreThe study analyzes data from women with pathogenic variants of the BRCA1 or BRCA2 genes and shows that those with BRCA1 sequence variations undergoing magnetic resonance imaging follow-up have a signi...
Read moreIn this context, the doctoral thesis of the Lorena Joga, child and youth neuropsychologist at Parc Taulí and member of the I3PT Growth and Developmental Disorders Research Group, with the title "Frag...
Read moreThe DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...
Read moreIt has been demonstrated in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain inju...
Read moreThe Orphan Drug Designation indicates the acknowledgement by the Regulatory Authorities of USA and the EU that PBF-999 have the potential to address the specific needs of individuals suffering from Pr...
Read more